2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- DXCM
- MSFT
Let's look at two top stocks that have performed worse than the broader market this year: DexCom (NASDAQ: DXCM) and Microsoft (NASDAQ: MSFT). Shares of medical devices specialist DexCom have dropped by 39% year to date. DexCom's own G6 CGM system continues to be highly successful.